期刊： PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021; 75 (4)
Background Schizophrenia (SCZ) is a serious psychiatric disorder. Metabolite disturbance is an important pathogenic factor in schizophrenic patients. ......
期刊： PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020; 74 (6)
Aim The aim of the present study was to evaluate the efficacy and safety of lurasidone for the treatment of Chinese schizophrenic patients. Methods Ho......
期刊： PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020; 74 (4)
Aim There is increasing evidence that mild cognitive impairment (MCI) is associated with widespread brain dysconnectivity. Mindfulness practice, which......
期刊： PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020; 74 (6)
Aim We aimed to estimate the network structures of depressive symptoms using network analysis and evaluated the geographic regional differences in the......
期刊： PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020; 74 (9)
Aim The clinical features of schizophrenia can be mainly divided into two symptom domains: positive and negative. Patients in each symptom domain resp......
